Moving toward an understanding of hormone replacement therapy in adolescent girls: Looking through the lens of Turner syndrome

Annals of the New York Academy of Sciences

Volumn 1135, Issue , 2008, Pages 126-137

  Davenport, Marsha L ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Body height; Conjugated estrogens; Drug administration routes; Estradiol; Estrogens; Ethinyl estradiol; FSH; Growth failure; Human growth hormone; Karyotyping; Lymphogenesis; Ovarian failure; Pubertal delay; Short stature; SHOX; Turner syndrome; X chromosome

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; ETHINYLESTRADIOL; FOLLITROPIN; GESTAGEN; GONADOTROPIN; GROWTH HORMONE; LUTEINIZING HORMONE; PROGESTERONE; SEX HORMONE; SOMATOMEDIN; VIVELLE DOT PATCH;

ADOLESCENT; BEDTIME DOSAGE; BRAIN DEVELOPMENT; BRAIN FUNCTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COGNITION; CONFERENCE PAPER; DEVELOPMENTAL DISORDER; DISEASE ASSOCIATION; ESTROGEN DEFICIENCY; ESTROGEN RELEASE; ESTROGEN THERAPY; FOLLITROPIN RELEASE; GONAD FUNCTION; GONADAL DYSGENESIS; GONADOTROPIN BLOOD LEVEL; HORMONE RELEASE; HUMAN; HYPOGONADISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTELLIGENCE; KARYOTYPING; LOW DRUG DOSE; LUTEINIZING HORMONE RELEASE; MENSTRUATION DISORDER; MOOD; NONHUMAN; RECOMMENDED DRUG DOSE; SHORT STATURE; TURNER SYNDROME; X CHROMOSOME;

EID: 45549107029     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1429.031     Document Type: Conference Paper

References (78)

1. Bondy, C.A. for the The Turner Syndrome Consensus Study Group. 2007. Care of Girls and Women with Turner Syndrome: A Guideline of the Turner Syndrome Study Group. J. Clin. Endocrinol. Metab. 92 : 10 25.
2. Hook, E.B. & D. Warburton. 1983. The distribution of chromosomal genotypes associated with Turner's syndrome: livebirth prevalence rates and evidence for diminished fetal mortality and severity in genotypes associated with structural X abnormalities or mosaicism. Hum. Genet. 64 : 24 27.
3. Nielsen, J. & M. Wohlert. 1991. Chromosome abnormalities found among 34, 910 newborn children: results from a 13-year incidence study in Aarhus, Denmark. Hum. Genet. 87 : 81 83.
4. Chow, J.C., Z. Yen, S.M. Ziesche & C.J. Brown. 2005. Silencing of the mammalian X chromosome. Annu. Rev. Genomics Hum. Genet. 6 : 69 92 69 92.
5. Carrel, L. & H.F. Willard. 2005. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 434 : 400 404.
6. Sybert, V.P. & E. McCauley. 2004. Turner's syndrome. N. Engl. J. Med. 351 : 1227 1238.
7. Savendahl, L. & M.L. Davenport. 2000. Delayed diagnoses of Turner's syndrome: proposed guidelines for change. J. Pediatr. 137 : 455 459.
8. Gunther, D.F., E. Eugster, A.J. Zagar, et al. 2004. Ascertainment bias in Turner syndrome: new insights from girls who were diagnosed incidentally in prenatal life. Pediatrics 114 : 640 644.
9. Rao, E., B. Weiss, M. Fukami, et al. 1997. Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome [see comments]. Nat. Genet. 16 : 54 63.
10. Ellison, J.W., Z. Wardak, M.F. Young, et al. 1997. PHOG, a candidate gene for involvement in the short stature of Turner syndrome. Hum. Mol. Genet. 6 : 1341 1347.
11. Clement-Jones, M., S. Schiller, E. Rao, et al. 2000. The short stature homeobox gene SHOX is involved in skeletal abnormalities in Turner syndrome. Hum. Mol. Genet. 9 : 695 702.
12. Marchini, A., G. Rappold & K.U. Schneider. 2007. SHOX at a glance: from gene to protein. Arch. Physiol. Biochem. 113 : 116 123.
13. Marchini, A., B. Hacker, T. Marttila, et al. 2007. BNP is a transcriptional target of the short stature homeobox gene SHOX. Hum. Mol. Genet. 16 : 3081 3087.
14. Suda, M., Y. Ogawa, K. Tanaka, et al. 1998. Skeletal overgrowth in transgenic mice that overexpress brain natriuretic peptide. Proc. Natl. Acad. Sci. USA 95 : 2337 2342.
15. Kajii, T., A. Ferrier, N. Niikawa, et al. 1980. Anatomic and chromosomal anomalies in 639 spontaneous abortuses. Hum. Genet. 55 : 87 98.
16. Simpson, J.L. & A. Rajkovic. 1999. Ovarian differentiation and gonadal failure. Am. J Med. Genet. 89 : 186 200.
17. Jones, M.H., R.A. Furlong, H. Burkin, et al. 1996. The Drosophila developmental gene fat facets has a human homologue in Xp11.4 which escapes X-inactivation and has related sequences on Yq11.2. Hum. Mol. Genet. 5 : 1695 1701.
18. Dube, J.L., P. Wang, J. Elvin, et al. 1998. The bone morphogenetic protein 15 gene is X-linked and expressed in oocytes. Mol. Endocrinol. 12 : 1809 1817.
19. Baker, T.G. 1963. A quantitative and cytological study of germ cells in human ovaries. Proc. R. Soc. Lond. Ser. B Biol. Sci. 158 : 417 Sane & D. Bhartiya. 2003. Accelerated germ cell apoptosis in sex chromosome aneuploid fetal human gonads. Mol. Hum. Reprod. 9 : 219 225.
20. Speed, R.M. 1988. The possible role of meiotic pairing anomalies in the atresia of human fetal oocytes. Hum. Genet. 78 : 260 266.
21. Grumbach, M.M. 2005. A window of opportunity: the diagnosis of gonadotropin deficiency in the male infant. J. Clin. Endocrinol. Metab. 90 : 3122 3127.
22. Chrysis, D., B.E. Spiliotis, M. Stene, et al. 2006. Gonadotropin secretion in girls with Turner syndrome measured by an ultrasensitive immunochemiluminometric assay. Horm. Res. 65 : 261 266.
23. Fechner, P.Y., M.L. Davenport, R.L. Qualy, et al. 2006. Differences in follicle-stimulating hormone secretion between 45, X monosomy Turner syndrome and 45, X/46, XX mosaicism are evident at an early age. J. Clin. Endocrinol. Metab. 91 : 4896 4902.
24. Wilson, C.A., C. Heinrichs, K.A. Larmore, et al. 2003. Estradiol levels in girls with Turner's syndrome compared to normal prepubertal girls as determined by an ultrasensitive assay. J. Pediatr. Endocrinol. Metab. 16 : 91 96.
25. Pasquino, A.M., F. Passeri, I. Pucarelli, et al. 1997. Spontaneous pubertal development in Turner's syndrome. Italian Study Group for Turner's Syndrome. J. Clin. Endocrinol. Metab. 82 : 1810 1813.
26. Davenport, M.L., N. Punyasavatsut, D. Gunther, et al. 1999. Turner syndrome: a pattern of early growth failure. Acta Paediatr. Suppl. 88 : 118 121.
27. Ranke, M.B., H. Pfluger, W. Rosendahl, et al. 1983. Turner syndrome: spontaneous growth in 150 cases and review of the literature. Eur. J. Pediatr. 141 : 81 88.
28. Davenport, M.L. & S.M. de Muinck Keizer-Schrama. 2006. Growth and Growth Hormone Treatment in Turner Syndrome. In Wellness for Girls and Women with Turner Syndrome. C.H. Gravholt & C.A. Bondy, Eds. : 33 41. Elsevier. Amsterdam.
29. Taback, S.P., R. Collu, C.L. Deal, et al. 1996. Does growth-hormone supplementation affect adult height in Turner's syndrome? Lancet 348 : 25 27.
30. Van Pareren, Y.K., S.M. de Muinck Keizer-Schrama, T. Stijnen, et al. 2003. Final height in girls with Turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens. J. Clin. Endocrinol. Metab. 88 : 1119 1125.
31. The Canadian Growth Hormone Advisory Committee. 2005. Impact of growth hormone supplementation on adult height in Turner syndrome: results of the Canadian randomized controlled trial. J. Clin. Endocrinol. Metab. 90 : 3360 3366.
32. Soriano-Guillen, L., J. Coste, E. Ecosse, et al. 2005. Adult height and pubertal growth in Turner syndrome after treatment with recombinant growth hormone. J. Clin. Endocrinol. Metab. 90 : 5197 5204.
33. Parker, K.L., D.T. Wyatt, S.L. Blethen, et al. 2003. Screening girls with Turner syndrome: the National Cooperative Growth Study experience. J. Pediatr. 143 : 133 135.
34. Ranke, M.B., A. Lindberg, P. Chatelain, et al. 2000. Prediction of long-term response to recombinant human growth hormone in Turner syndrome: development and validation of mathematical models. KIGS International Board. Kabi International Growth Study. J. Clin. Endocrinol. Metab. 85 : 4212 4218.
35. Davenport, M.L., B.J. Crowe, S.H. Travers, et al. 2007. Growth hormone treatment of early growth failure in toddlers with Turner syndrome: a randomized, controlled, multicenter trial. J. Clin. Endocrinol. Metab. 92 : 3406 3416.
36. Chernausek, S.D., K.M. Attie, J.F. Cara, et al. 2000. Growth hormone therapy of Turner syndrome: the impact of age of estrogen replacement on final height. Genentech, Inc., Collaborative Study Group. J. Clin. Endocrinol. Metab. 85 : 2439 2445.
37. Sas, T.C., K. de Muinck, T. Stijnen, et al. 1999. Normalization of height in girls with Turner syndrome after long-term growth hormone treatment: results of a randomized dose-response trial. J. Clin. Endocrinol. Metab. 84 : 4607 4612.
38. Reiter, E.O., S.L. Blethen, J. Baptista & L. Price. 2001. Early initiation of growth hormone treatment allows age-appropriate estrogen use in Turner's syndrome. J. Clin. Endocrinol. Metab. 86 : 1936 1941.
39. Weissberger, A.J., K.K. Ho & L. Lazarus. 1991. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin- like growth factor I, and GH-binding protein in postmenopausal women. J. Clin. Endocrinol. Metab. 72 : 374 381.
40. Janssen, Y.J.H., F. Helmerhorst, M. Frolich & F. Roelfsema. 2000. A switch from oral (2 mg/day) to transdermal (50 {micro}g/day) 17{beta}-estradiol therapy increases serum insulin-like growth factor-I levels in recombinant human growth hormone (GH)-substituted women with GH deficiency. J. Clin. Endocrinol. Metab. 85 : 464 467.
41. Rosenfield, R.L., N. Devine, J.J. Hunold, et al. 2005. Salutary effects of combining early very low-dose systemic estradiol with growth hormone therapy in girls with Turner syndrome. J. Clin. Endocrinol. Metab. 90 : 6424 6430.
42. Hogler, W., J. Briody, B. Moore, et al. 2004. Importance of estrogen on bone health in Turner syndrome: a cross-sectional and longitudinal study using dual-energy X-ray absorptiometry. J. Clin. Endocrinol. Metab. 89 : 193 199.
43. Bechtold, S., F. Rauch, V. Noelle, et al. 2001. Musculoskeletal analyses of the forearm in young women with Turner syndrome: a study using peripheral quantitative computed tomography. J. Clin. Endocrinol. Metab. 86 : 5819 5823.
44. Stochholm, K., S. Juul, K. Juel, et al. 2006. Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome. J. Clin. Endocrinol. Metab. 91 : 3897 3902.
45. Mazzanti, L. & E. Cacciari. 1998. Congenital heart disease in patients with Turner's syndrome. Italian Study Group for Turner Syndrome (ISGTS). J. Pediatr. 133 : 688 692.
46. Gravholt, C.H., K. Landin-Wilhelmsen, K. Stochholm, et al. 2006. Clinical and epidemiological description of aortic dissection in Turner's syndrome. Cardiol. Young. 16 : 430 436.
47. Ostberg, J.E., C. Storry, A.E. Donald, et al. 2007. A dose-response study of hormone replacement in young hypogonadal women: effects on intima media thickness and metabolism. Clin. Endocrinol. (Oxf.) 66 : 557 564.
48. Baguet, J.P., S. Douchin, H. Pierre, et al. 2005. Structural and functional abnormalities of large arteries in Turner syndrome. Heart 91 : 1442 1446.
49. Landin-Wilhelmsen, K., I. Bryman & L. Wilhelmsen. 2001. Cardiac malformations and hypertension, but not metabolic risk factors, are common in Turner syndrome. J. Clin. Endocrinol. Metab. 86 : 4166 4170.
50. Kozlowska-Wojciechowska, M., W. Jez, T. Zdrojewski & K. Chwojnicki. 2006. Are young women with Turner syndrome at greater risk of coronary artery disease? Eur. J. Cardiovasc. Prev Rehabil. 13 : 467 469.
51. Nathwani, N.C., R. Unwin, C.G. Brook & P.C. Hindmarsh. 2000. Blood pressure and Turner syndrome. Clin. Endocrinol. (Oxf.) 52 : 363 370.
52. Hayward, C.S., D.C. Knight, B.G. Wren & R.P. Kelly. 1997. Effect of hormone replacement therapy on non-invasive cardiovascular haemodynamics. J. Hypertens. 15 : 987 993.
53. Gravholt, C.H., R.W. Naeraa, B. Nyholm, et al. 1998. Glucose metabolism, lipid metabolism, and cardiovascular risk factors in adult Turner's syndrome: the impact of sex hormone replacement. Diab. Care 21 : 1062 1070.
54. Davenport, M.L., S.R. Hooper & M. Zeger. 2007. Turner syndrome in childhood. In Neurogenetic Developmental Disorders: Variation of Manifestation in Childhood. M.M.M. Mazzocco & J.L. Ross, Eds. 3 45. The MIT Press. Cambridge, MA.
55. Brown, W.E., S.R. Kesler, S. Eliez, et al. 2004. A volumetric study of parietal lobe subregions in Turner syndrome. Dev. Med. Child. Neurol. 46 : 607 609.
56. Murphy, D.G., C. DeCarli, E. Daly, et al. 1993. X-chromosome effects on female brain: a magnetic resonance imaging study of Turner's syndrome [see comments]. Lancet 342 : 1197 1200.
57. Reiss, A.L., M.M. Mazzocco, R. Greenlaw, et al. 1995. Neurodevelopmental effects of X monosomy: a volumetric imaging study. Ann. Neurol. 38 : 731 738.
58. Clark, C., H. Klonoff & M. Hayden. 1990. Regional cerebral glucose metabolism in Turner syndrome. Can. J. Neurol. Sci. 17 : 140 144.
59. Hart, S.J., M.L. Davenport, S.R. Hooper & A. Belger. 2006. Visuospatial executive function in Turner syndrome: functional MRI and neurocognitive findings Brain 129 : 1125 1136.
60. Kesler, S.R., A. Garrett, B. Bender, et al. 2004. Amygdala and hippocampal volumes in Turner syndrome: a high-resolution MRI study of X-monosomy. Neuropsychologia 42 : 1971 1978.
61. Tamm, L., V. Menon & A.L. Reiss. 2003. Abnormal prefrontal cortex function during response inhibition in Turner syndrome: functional magnetic resonance imaging evidence. Biol. Psychiatry 53 : 107 111.
62. Haberecht, M.F., V. Menon, I.S. Warsofsky, et al. 2001. Functional neuroanatomy of visuo-spatial working memory in Turner syndrome. Hum. Brain Mapp. 14 : 96 107.
63. Skuse, D.H., J.S. Morris & R.J. Dolan. 2005. Functional dissociation of amygdala-modulated arousal and cognitive appraisal, in Turner syndrome. Brain 128 : 2084 2096.
64. Ross, J., D. Roeltgen & A. Zinn. 2006. Cognition and the sex chromosomes: studies in Turner syndrome. Horm. Res. 65 : 47 56.
65. Kudwa, A.E., V. Michopoulos, J.D. Gatewood & E.F. Rissman. 2006. Roles of estrogen receptors [alpha] and [beta] in differentiation of mouse sexual behavior. Neuroscience 138 : 921 928.
66. Lenroot, R.K., N. Gogtay, D.K. Greenstein, et al. 2007. Sexual dimorphism of brain developmental trajectories during childhood and adolescence. Neuroimage 36 : 1065 1073.
67. Rosenberg, L. & S. Park. 2002. Verbal and spatial functions across the menstrual cycle in healthy young women. Psychoneuroendocrinology 27 : 835 841.
68. Ancelin, M.L. & K. Ritchie. 2005. Lifelong endocrine fluctuations and related cognitive disorders. Curr. Pharm. Des. 11 : 4229 4252.
69. Ross, J.L., D. Roeltgen, P. Feuillan, et al. 2000. Use of estrogen in young girls with Turner syndrome: effects on memory. Neurology 54 : 164 170.
70. Ross, J.L., D. Roeltgen, P. Feuillan, et al. 1998. Effects of estrogen on nonverbal processing speed and motor function in girls with Turner's syndrome. J. Clin. Endocrinol. Metab. 83 : 3198 3204.
71. Drobac, S., K. Rubin, A.D. Rogol & R.L. Rosenfield. 2006. A workshop on pubertal hormone replacement options in the United States J Pediatr. Endocrinol. Metab. 19 : 55 64.
72. Kiess, W., G. Conway, M. Ritzen, et al. 2002. Induction of puberty in the hypogonadal girl-practices and attitudes of pediatric endocrinologists in Europe. Horm. Res. 57 : 66 71.
73. Ankarberg-Lindgren, C.A., M. Elfving, K.A. Wikland & E. Norjavaara. 2001. Nocturnal application of transdermal estradiol patches produces levels of estradiol that mimic those seen at the onset of spontaneous puberty in girls. J. Clin. Endocrinol. Metab. 86 : 3039 3044.
74. Rosenfield, R.L., N. Perovic, N. Devine, et al. 1998. Optimizing estrogen replacement treatment in Turner syndrome. Pediatrics 102 : 486 488.
75. Piippo, K.S., H. Lenko, P. Kainulainen & I. Sipila. 2005. Use of percutaneous estrogen gel for induction of puberty in girls with Turner syndrome. Obstet. Gynecol. Surv. 60 : 102 103.
76. Bhavnani, B.R. 1998. Pharmacokinetics and pharmacodynamics of conjugated equine estrogens: chemistry and metabolism. Proc. Soc. Exp. Biol. Med. 217 : 6 16.
77. Gravholt, C.H. 2005. Clinical practice in Turner syndrome. Nat. Clin. Pract. Endocrinol. Metab. 1 : 41 52.
78. Ross, J.L., C.A. Quigley, D. Cao, et al. 2007. Early low-dose increases adult height gain in GH-treated patients with Turner syndrome (TS): Results of a double-blind, randomized, placebo-controlled clinical trial. E-PAS 61 abstr).